CAPRICOR THERAPEUTICS, INC. Related Party Transaction, Other Revenues from Transactions with Related Party
CAPRICOR THERAPEUTICS, INC. (CAPR) reported Related Party Transaction, Other Revenues from Transactions with Related Party of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-17.
Discontinued › Income Statement › Other Income
us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty · last filed 2023-03-17
- CAPRICOR THERAPEUTICS, INC. related party transaction, other revenues from transactions with related party for the quarter ending 2022-12-31 was $0.00.
- CAPRICOR THERAPEUTICS, INC. related party transaction, other revenues from transactions with related party for the quarter ending 2022-09-30 was $0.00.
- CAPRICOR THERAPEUTICS, INC. related party transaction, other revenues from transactions with related party for the quarter ending 2022-06-30 was $0.00, a 100.00% decline year-over-year.
- CAPRICOR THERAPEUTICS, INC. related party transaction, other revenues from transactions with related party for the quarter ending 2022-03-31 was $0.00, a 100.00% decline year-over-year.
- CAPRICOR THERAPEUTICS, INC. related party transaction, other revenues from transactions with related party for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- CAPRICOR THERAPEUTICS, INC. related party transaction, other revenues from transactions with related party for fiscal 2021 was $245.00K, a 104.17% increase from fiscal 2020.
- CAPRICOR THERAPEUTICS, INC. related party transaction, other revenues from transactions with related party for fiscal 2020 was $120.00K, a 73.91% decline from fiscal 2019.
- CAPRICOR THERAPEUTICS, INC. related party transaction, other revenues from transactions with related party for fiscal 2019 was $460.00K, a 34.29% decline from fiscal 2018.
| Period end | Related Party Transaction, Other Revenues from Transactions with Related Party 3 month | Related Party Transaction, Other Revenues from Transactions with Related Party 6 month | Related Party Transaction, Other Revenues from Transactions with Related Party 9 month | Related Party Transaction, Other Revenues from Transactions with Related Party 9 month as first filed | Related Party Transaction, Other Revenues from Transactions with Related Party 12 month |
|---|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-17 | $0.00 derived: sum of 2 quarters · filed 2023-03-17 | $0.00 derived: sum of 3 quarters · filed 2023-03-17 | $0.00 10-K · filed 2023-03-17 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $0.00 derived: sum of 2 quarters · filed 2022-11-10 | $0.00 10-Q · filed 2022-11-10 | $0.00 derived: sum of 4 quarters · filed 2023-03-17 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $0.00 10-Q · filed 2022-08-12 | $0.00 derived: sum of 3 quarters · filed 2023-03-17 | $0.00 derived: sum of 4 quarters · filed 2023-03-17 | |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-11 | $0.00 derived: sum of 2 quarters · filed 2023-03-17 | $0.00 derived: sum of 3 quarters · filed 2023-03-17 | $204.20K derived: sum of 4 quarters · filed 2023-03-17 | |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-17 | $0.00 derived: sum of 2 quarters · filed 2023-03-17 | $204.20K derived: sum of 3 quarters · filed 2023-03-17 | $245.00K 10-K · filed 2023-03-17 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $204.20K derived: sum of 2 quarters · filed 2022-11-10 | $245.00K 10-Q · filed 2022-11-10 | $298.00K derived: sum of 4 quarters · filed 2022-11-10 | |
| 2021-06-30 | $204.20K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $245.00K 10-Q · filed 2022-08-12 | $298.00K derived: sum of 3 quarters · filed 2022-08-12 | $298.00K derived: sum of 4 quarters · filed 2022-08-12 | |
| 2021-03-31 | $40.80K 10-Q · filed 2022-05-11 | $93.80K derived: sum of 2 quarters · filed 2022-05-11 | $93.80K derived: sum of 3 quarters · filed 2022-05-11 | $93.80K derived: sum of 4 quarters · filed 2022-05-11 | |
| 2020-12-31 | $53.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $53.00K derived: sum of 2 quarters · filed 2022-03-11 | $53.00K derived: sum of 3 quarters · filed 2022-03-11 | $120.00K 10-K · filed 2022-03-11 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $0.00 derived: sum of 2 quarters · filed 2021-11-12 | $67.00K 10-Q · filed 2021-11-12 | $244.00K derived: sum of 4 quarters · filed 2021-11-12 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | $67.00K 10-Q · filed 2021-08-13 | $244.00K derived: sum of 3 quarters · filed 2021-08-13 | $285.00K derived: sum of 4 quarters · filed 2021-08-13 | |
| 2020-03-31 | $67.00K 10-Q · filed 2021-05-14 | $244.00K derived: sum of 2 quarters · filed 2021-05-14 | $285.00K derived: sum of 3 quarters · filed 2021-05-14 | $460.00K derived: sum of 4 quarters · filed 2021-05-14 | |
| 2019-12-31 | $177.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | $218.00K derived: sum of 2 quarters · filed 2021-03-15 | $393.00K derived: sum of 3 quarters · filed 2021-03-15 | $460.00K 10-K · filed 2021-03-15 | |
| 2019-09-30 | $41.00K 10-Q · filed 2019-11-08 | $216.00K derived: sum of 2 quarters · filed 2019-11-08 | $283.00K 10-Q · filed 2020-11-13 | $324.00K 10-Q · filed 2019-11-08 | $767.00K derived: sum of 4 quarters · filed 2020-05-15 |
| 2019-06-30 | $175.00K 10-Q · filed 2019-08-08 | $283.00K 10-Q · filed 2020-08-10 | $726.00K derived: sum of 3 quarters · filed 2020-05-15 | $773.00K derived: sum of 4 quarters · filed 2020-05-15 | |
| 2019-03-31 | $108.00K 10-Q · filed 2020-05-15 | $551.00K derived: sum of 2 quarters · filed 2020-05-15 | $598.00K derived: sum of 3 quarters · filed 2020-05-15 | $715.00K derived: sum of 4 quarters · filed 2020-05-15 | |
| 2018-12-31 | $443.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | $490.00K derived: sum of 2 quarters · filed 2020-03-27 | $607.00K derived: sum of 3 quarters · filed 2020-03-27 | $700.00K 10-K · filed 2020-03-27 | |
| 2018-09-30 | $47.00K 10-Q · filed 2019-11-08 | $164.00K derived: sum of 2 quarters · filed 2019-11-08 | $257.00K 10-Q · filed 2019-11-08 | $388.50K derived: sum of 4 quarters · filed 2019-11-08 | |
| 2018-06-30 | $117.00K 10-Q · filed 2019-08-08 | $210.00K 10-Q · filed 2019-08-08 | $341.50K derived: sum of 3 quarters · filed 2019-08-08 | $394.00K derived: sum of 4 quarters · filed 2019-08-08 | |
| 2018-03-31 | $93.00K 10-Q · filed 2019-05-14 | $224.50K derived: sum of 2 quarters · filed 2019-05-14 | $277.00K derived: sum of 3 quarters · filed 2019-05-14 | ||
| 2017-12-31 | $131.50K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | $184.00K derived: sum of 2 quarters · filed 2019-03-29 | $184.00K 10-K · filed 2019-03-29 | ||
| 2017-09-30 | $52.50K 10-Q · filed 2018-11-14 | $52.50K 10-Q · filed 2018-11-14 | |||
| 2017-06-30 | $0.00 10-Q · filed 2018-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |